Wendy White is a thought leader working in rare diseases at the intersection of business, advocacy and technology. She was a pioneer in recognizing the power of patients and caregivers in influencing their own and their loved one’s outcomes and formulating innovative strategies for all stakeholders to work together for a common cause. Wendy is bringing her expertise learned in working with over 36 rare communities on behalf of manufacturers, her experience on the board of both the National Organization of Rare Disorders (NORD) and Global Genes and an outstanding network in rare pharma to a consulting offering for pharmaceutical companies, bio-tech, service organizations and venture companies. With 20 years in rare disease, Wendy brings one of the industry's strongest track records to a slate of services that help clients efficiently and effectively identify the most compelling patient-engagement opportunities, as well as potential gaps that can impact commercialization plans for orphan drug launches.
Tiffany Leighton Ozmina
(847) 467-2303
Email